Gefitinib (ZD1839) monotherapy as a salvage regimen for previously treated advanced non-small cell lung cancer.
Park J, Park BB, Kim JY, Lee SH, Lee SI, Kim HY, Kim JH, Park SH, Lee KE, Park JO, Kim K, Jung CW, Park YS, Im YH, Kang WK, Lee MH, Park K.
Park J, et al. Among authors: kim jy, kim hy, kim jh, kim k.
Clin Cancer Res. 2004 Jul 1;10(13):4383-8. doi: 10.1158/1078-0432.CCR-04-0189.
Clin Cancer Res. 2004.
PMID: 15240526